Dodd G W, Ibbertson H K, Fraser T R, Holdaway I M, Wattie D
Department of Radiology, Auckland Hospital, New Zealand.
Br J Radiol. 1987 Sep;60(717):849-60. doi: 10.1259/0007-1285-60-717-849.
The effects of therapy on the osteolytic bone lesions of Paget's disease have been assessed from serial bone radiographs. Changes in the rate of progression of lytic "wedge" lesions were measured and alterations in the texture of lytic "blade" lesions were graded on an empirical scale. Useful matching was possible using standard radiographs, although special care was needed to avoid artefacts from suboptimal positioning, magnification and variation in exposure. Serial radiographs were obtained of 57 lytic blade lesions in 54 patients receiving treatment with the bisphosphonate 1-hydroxyethylidene-1, 1-bisphosphonate (EHDP) and of 20 lesions in 20 patients treated with oral or intravenous 3-amino-1-hydroxypropylidene-1, 1-bisphosphonate (APD). Treatment with EHDP was associated with a significant deterioration in bone texture in 50% of lytic blade lesions, and with healing in only 20%. Deterioration was accompanied by an increase in local bone pain in 17% of these patients. In contrast, significant healing was observed in 17 of 20 lytic lesions (eight wedge, nine blade) within 6 months of beginning a course of intravenous or oral APD. In four of eight patients the progression of a lytic tibial wedge was arrested and in the remaining four the direction of wedge movement was reversed. In two patients the wedge had almost completely "filled in", making measurement difficult. Bone healing was usually accompanied by pain relief, reduction in skin temperature and rapid suppression of the urine hydroxyproline (uHP) into the normal range. However, in four patients who received intravenous APD, repair of lytic bone lesions was observed despite persisting elevation of uHP. These improvements with APD were sustained at 12 months, although in one patient whose biochemical indices were restored to normal the resorption front showed further progression, despite initial temporary reversal. The trends apparent in these short-term studies were also seen in four patients in whom wedge velocities were measured over periods of 6-10 years. These results confirm that after treatment of Paget's disease, bone healing or deterioration can be accurately assessed from serial standard radiographs. Reproducible matching is best achieved by ensuring that all radiographs are taken by the same radiographer. Minor alterations in radiological bone texture provide an important index of drug effect which is not always apparent from measurement of biochemical and other indices.
通过连续骨X光片评估了治疗对佩吉特病溶骨性骨病变的影响。测量了溶骨性“楔形”病变进展速度的变化,并根据经验量表对溶骨性“片状”病变的质地改变进行了分级。使用标准X光片可以进行有效的匹配,不过需要特别注意避免因定位欠佳、放大和曝光差异导致的伪影。对54例接受双膦酸盐1-羟基亚乙基-1,1-二膦酸盐(EHDP)治疗的患者的57个溶骨性片状病变以及20例接受口服或静脉注射3-氨基-1-羟基亚丙基-1,1-二膦酸盐(APD)治疗的患者的20个病变进行了连续X光片检查。EHDP治疗使50%的溶骨性片状病变的骨质地显著恶化,仅有20%出现愈合。在这些患者中,17%的患者骨质地恶化伴有局部骨痛加剧。相比之下,在开始静脉注射或口服APD疗程的6个月内,20个溶骨性病变中有17个(8个楔形、9个片状)出现了显著愈合。在8例患者中有4例溶骨性胫骨楔形病变的进展停止,其余4例楔形病变的移动方向逆转。在2例患者中,楔形几乎完全“填充”,导致测量困难。骨愈合通常伴随着疼痛缓解、皮肤温度降低以及尿羟脯氨酸(uHP)迅速降至正常范围。然而,在4例接受静脉注射APD的患者中,尽管uHP持续升高,但仍观察到溶骨性骨病变的修复。APD带来的这些改善在12个月时得以维持,不过有1例生化指标恢复正常的患者,尽管最初有暂时逆转,但吸收前沿仍显示进一步进展。在对4例患者进行了6 - 10年的楔形速度测量中,也观察到了这些短期研究中明显的趋势。这些结果证实,在佩吉特病治疗后,通过连续标准X光片可以准确评估骨愈合或恶化情况。通过确保所有X光片由同一位放射技师拍摄,可实现最佳的可重复性匹配。放射学骨质地的微小改变提供了药物效果的重要指标,这在生化指标和其他指标的测量中并不总是明显的。